AzTrials
AzTrials

Pressure UlcerNCT03597750

Comparison of Static Air Support Devices (Repose®) and Alternating-Pressure Devices in the Prevention of Pressure Ulcers

A study testing Repose® in people with Pressure Ulcer and Pressure Injury, run by University Ghent at 26 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Maintaining and improving skin health are major goals in acute and long-term care. Patients at the extremes of age, the critically ill, medically compromised and those with immobility are at risk for developing several skin disorders, with pressure ulcers (PUs) as one of the most common and mostly preventable ones. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Pressure Ulcer, Pressure Injury, Pressure Sore
What is being tested?
Repose®
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
308 participants
Where
26 sitesBelgium
Study dates
19 Apr 2017to 15 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • High risk of pressure ulcers (Braden score < 12) and/or pressure ulcer category 1
  • Currently using alternating-pressure devices
  • Bedbound (> 8 hours in bed) or chair bound (> 8 hours in chair)
  • Aged > 65 years

Who cannot join

  • Pressure ulcer category 2,3,4, deep tissue injury (DTI) or unstageable pressure ulcer
  • Expected length of stay < 2 weeks
  • End of life care
  • Medical contraindication for use of static air support devices

Trial locations and contacts

26 sites in 1 country.

26 sites in 1 country

Belgium26 sites
  • Woonzorgcentrum Veilige Have

    Aalter, Oost-Vlaanderen

  • Woonzorgcentrum Zonnetij

    Aartselaar, Antwerpen

  • Woonzorgcentrum Zonnewende

    Aartselaar, Antwerpen

  • Woonzorgcentrum Sint-Jozef

    Assenede, Oost-Vlaanderen

  • Woonzorgcentrum Sint-Vincentius

    Avelgem, West-Vlaanderen

  • Woonzorgcentrum De Mick

    Brasschaat, Antwerpen

  • Woonzorgcentrum Sint-Maria

    Brecht, Antwerpen

  • Woonzorgcentrum Hallenhuis

    Bruges, West-Vlaanderen

  • Woonzorgcentrum Minnewater

    Bruges, West-Vlaanderen

  • Woonzorgcentrum Ter Potterie

    Bruges, West-Vlaanderen

  • Woonzorgcentrum Van Zuylen

    Bruges, West-Vlaanderen

  • Woonzorgcentrum De Vijvers

    Gentbrugge, Oost-Vlaanderen

  • Woonzorgcentrum Meulenbroek

    Hamme, Oost-Vlaanderen

  • Woonzorgcentrum Huize Zonnelied

    Ieper, West-Vlaanderen

  • Woonzorgcentrum Maria Rustoord

    Ingelmunster, West-Vlaanderen

  • Woonzorgcentrum De Plataan

    Izegem, West-Vlaanderen

  • Woonzorgcentrum De Pottelberg

    Kortrijk, West-Vlaanderen

  • Woonzorgcentrum Sint-Jozef

    Kortrijk, West-Vlaanderen

  • Woonzorgcentrum Heilig Hart

    Oudenaarde, Oost-Vlaanderen

  • Woonzorgcentrum OLV Gasthuis

    Poperinge, West-Vlaanderen

  • Woonzorgcentrum Hof Ten Ijzer

    Reninge, West-Vlaanderen

  • Woonzorgcentrum Wintershove

    Vlamertinge, West-Vlaanderen

  • Woonzorgcentrum De Meers

    Waregem, West-Vlaanderen

  • Woonzorgcentrum Sint-Camillus

    Wevelgem, West-Vlaanderen

  • Woonzorgcentrum Egmont

    Zottegem, Oost-Vlaanderen

  • Woonzorgcentrum Sint-Amand

    Zwevegem, West-Vlaanderen

Other trials in Belgium

About this study

Official title: Pressure Ulcer Prevention Using Static Air Support Devices (Repose®) Versus Alternating-Pressure Devices in a High Risk Population in Nursing Homes: A Multi-Center Prospective Randomized Controlled Trial and Qualitative Study

Maintaining and improving skin health are major goals in acute and long-term care. Patients at the extremes of age, the critically ill, medically compromised and those with immobility are at risk for developing several skin disorders, with pressure ulcers (PUs) as one of the most common and mostly preventable ones. Prevalence figures of PUs vary between 6.4% and 31.4%. PUs are described as localised injuries to the skin and/or underlying tissue, usually over a bony prominence, as a result of pressure or pressure combined with shear. Prevention of PUs is internationally seen to be a key quality indicator of care. To prevent PUs, reducing both the amount and the duration of pressure and shear at the pressure points of the body is strongly recommended. One of the interventions to achieving this, is the use of pressure-reducing devices (mattresses, cushions, etc.). Studies that compare the (cost-) effectiveness of different pressure-reducing devices are needed.

The primary aim of this study is to compare the (cost-) effectiveness of pressure ulcer prevention in high risk patients using static air support devices (Repose®) versus alternating-pressure devices. The second aim is to get insight in patients' experiences and perceptions of comfort using static air support devices and alternating-pressure devices. The third aim is to get insight in caretakers' perceptions of barriers and facilitators of the use of static air support devices and alternating-pressure devices and to reveal how these perceptions influence the readiness to use the products in clinical practice.

This randomized controlled trial will be performed in ca. 25 nursing homes in a random sample of 306 residents who are at high risk of developing pressure ulcers. Residents will be included in the study for a period of 14 days. Skin assessment and risk factor registration will be done on a daily basis by the nurses. Reliability checks and time measurements will be completed by the researcher.

Being tested
Repose®
Keywords
Static air support devices, Alternating-pressure devices, High risk population, Elderly, Prevention
Medical subject headings
Pressure Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Repose®Device

    • Repose® Mattress
    • Repose® Cushion
    • Repose® Wedge or Foot Protectors
Study groups in NCT03597750
Study groupRoleWhat they receive
Static air support devices (Repose®)ExperimentalAlternating-pressure devices will be replaced by static air support devices (Repose®) during 14 days: * Repose® Mattress * Repose® Cushion * Repose® Wedge or Foot Protectors The frequency of repositioning remains unchanged.
Receives: Device: Repose®
Alternating-pressure devicesNo interventionInstead of replacing the alternating-pressure devices by static air support devices (Repose®), the residents remain on their alternating-pressure devices. The frequency of repositioning remains unchanged.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure ulcer incidence (Cat. II+)

    Development of at least 1 pressure ulcer Cat. II+ during study period

    Measured: 14 days

Secondary outcomes (4)
  1. Patient experiences and perceptions using a static air mattress

    Patients experiences and perceptions of comfort using static air support devices and alternating-pressure mattresses. Patient acceptability [tolerance, (sleep) comfort, pain)

    Measured: 14 days

  2. Caretakers perceptions of barriers and facilitators to use static air mattress

    Nurses acceptability [barriers and facilitators].

    Measured: 14 days

  3. Incidence of incontinence-associated dermatitis (IAD)

    Development of at least 1 IAD during study period

    Measured: 14 days

  4. Cost of the intervention (Repose) versus the standard care (Alternating)

    Economic measures (from an organizational and patient perspective)

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2018
  2. Study start19 Apr 2017
  3. Primary completion15 Jul 2018
  4. Study completion15 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
308 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03597750
Sponsor's protocol ID
EC/2017/0266
Other IDs
B670201731706
Status last verified
Oct 2018
First submitted
23 Oct 2017
Last updated
3 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • McInnes E, Jammali-Blasi A, Bell-Syer SE, Dumville JC, Middleton V, Cullum N. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev. 2015 Sep 3;2015(9):CD001735. doi: 10.1002/14651858.CD001735.pub5.

    PubMed 26333288
  • Serraes B, Beeckman D. Static Air Support Surfaces to Prevent Pressure Injuries: A Multicenter Cohort Study in Belgian Nursing Homes. J Wound Ostomy Continence Nurs. 2016 Jul-Aug;43(4):375-8. doi: 10.1097/WON.0000000000000244.

    PubMed 27391289

Questions about this trial

What is this clinical trial studying?

A study testing Repose® in people with Pressure Ulcer and Pressure Injury, run by University Ghent at 26 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 26 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure ulcer incidence (Cat. II+) (time frame: 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03597750, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in